Search research articles
Contact Us
Filters
Showing results (151-160 of 162) with videos related to
Page
of 17
Sort By:
Signal Transduction and Targeted Therapy
|
July 13, 2025
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability
Diego A Pereira-Martins, Isabel Weinhäuser, Emmanuel Griessinger, et al.
Plos One
|
August 12, 2022
Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients
Abraham Rutgers, Peter E Westerweel, Bronno van der Holt, et al.
Blood Cancer Journal
|
June 19, 2023
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine
Jacobien R Hilberink, Isabelle A van Zeventer, Dana A Chitu, et al.
The Lancet. Haematology
|
November 1, 2023
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial
Michael Lübbert, Pierre W Wijermans, Michal Kicinski, et al.
Blood Cancer Journal
|
June 24, 2024
Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia
Maria L Salustiano-Bandeira, Amanda Moreira-Aguiar, Diego A Pereira-Martins, et al.
Haematologica
|
October 10, 2024
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy
Federico Mosna, Erika Borlenghi, Mark Litzow, et al.
American Journal of Human Genetics
|
November 3, 2015
Allelic Mutations of KITLG, Encoding KIT Ligand, Cause Asymmetric and Unilateral Hearing Loss and Waardenburg Syndrome Type 2
Celia Zazo Seco, Luciana Serrão de Castro, Josephine W van Nierop, et al.
British Journal of Haematology
|
October 20, 2022
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia
Diego A Pereira-Martins, Juan L Coelho-Silva, Isabel Weinhäuser, et al.
International Journal of Laboratory Hematology
|
September 14, 2020
Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure
Celalettin Ustun, Elizabeth A Morgan, Ethan M Ritz, et al.
Cancer Medicine
|
August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)
Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 162) with videos related to
Sort By:
Page
of 17
Signal Transduction and Targeted Therapy
|
July 13, 2025
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability
Diego A Pereira-Martins, Isabel Weinhäuser, Emmanuel Griessinger, et al.
Plos One
|
August 12, 2022
Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients
Abraham Rutgers, Peter E Westerweel, Bronno van der Holt, et al.
Blood Cancer Journal
|
June 19, 2023
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine
Jacobien R Hilberink, Isabelle A van Zeventer, Dana A Chitu, et al.
The Lancet. Haematology
|
November 1, 2023
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial
Michael Lübbert, Pierre W Wijermans, Michal Kicinski, et al.
Blood Cancer Journal
|
June 24, 2024
Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia
Maria L Salustiano-Bandeira, Amanda Moreira-Aguiar, Diego A Pereira-Martins, et al.
Haematologica
|
October 10, 2024
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy
Federico Mosna, Erika Borlenghi, Mark Litzow, et al.
American Journal of Human Genetics
|
November 3, 2015
Allelic Mutations of KITLG, Encoding KIT Ligand, Cause Asymmetric and Unilateral Hearing Loss and Waardenburg Syndrome Type 2
Celia Zazo Seco, Luciana Serrão de Castro, Josephine W van Nierop, et al.
British Journal of Haematology
|
October 20, 2022
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia
Diego A Pereira-Martins, Juan L Coelho-Silva, Isabel Weinhäuser, et al.
International Journal of Laboratory Hematology
|
September 14, 2020
Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure
Celalettin Ustun, Elizabeth A Morgan, Ethan M Ritz, et al.
Cancer Medicine
|
August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)
Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Page
of 17